Ovum is an AI health journal for women, centered on a conversational assistant (“Ovum Brain”) that combines symptoms, wearable data, test results, and lifestyle logs into a longitudinal picture explicitly framed as non-diagnostic and appointment-support only. Founded by Dr. Ariella Heffernan-Marks in Melbourne, it runs on a consumer subscription model plus an employer wellbeing offering, has raised roughly AUD $5.7M across pre-seed and seed rounds, and is currently available in Australia and New Zealand.
Key features
- Ovum Brain: conversational AI trained on six Health Factors (symptoms, reproductive health, medication, appointments, lifestyle, diet & fitness)
- Cycle tracking integrated with symptom and daily health logging
- Appointment-ready health summary exports for GPs/specialists
- Longitudinal memory that personalizes insights over time
- Opt-in anonymized data sharing for women’s health research
- Employer/workplace wellbeing offering with “Ovum-certified workplace” tiers
Strengths
- Founder is a practicing medical doctor specializing in reproductive biology
- AI built specifically on female-centric medical literature, not a generic health model
- Strong early traction (20,000+ downloads, 113,000+ AI conversations within months)
- Backed by notable investors (Admiralty Capital Group, Antler, Giant Leap); $18M valuation post-seed
- Active clinical trial partnerships (St George Hospital, Royal Hospital for Women)
Categories
Features
Add Review
Leave a Reply